Clinical Education InitiativeMenu
Search
Home > Courses > Effects of HIV on the Lung

Effects of HIV on the Lung

Effects of HIV on the Lung
Play
Sorry, this learning module is not available for mobile devices.
Original Presentation: 9/16/2014
Web Posting: 2/23/2015
Presenter
  • Robert J. Kaner, MD
    Associate Professor of Clinical Medicine and Genetic Medicine
    Weill Cornell Medical College, New York, NY
Learning Objectives
At the completion of this educational session, participants will:
  1. Be able to describe the lung manifestations of HIV, including opportunistic infections, conventional pneumonias, lung cancers, pulmonary hypertension and COPD.
  2. Know how the effects of HIV on the lung have changed from the pre-HAART era to the present.
  3. Understand the diagnostic criteria for COPD and emphysema.
Presenter Bio
Robert Kaner, MD
Dr. Kaner has expertise in interstitial lung diseases, lung complications of conditions such as HIV, cancer, chemotherapy, radiation and bone marrow transplantation, and is the medical director of the Ventilator Management Team. Dr. Kaner is the Principal Investigator of the Weill-Cornell site of the National Institute of Health (NIH)-sponsored Idiopathic Pulmonary Fibrosis Clinical Research Network, one of 11 in the US and the only center in the Northeast/Mid-Atlantic region of the country. He is the project leader of an NIH-sponsored study of the molecular basis of accelerated emphysema development in HIV-1 positive smokers, which is part of a Specialized Center of Clinically Oriented Research for chronic obstructive pulmonary disease (COPD). Dr. Kaner is committed to research into the application of cutting edge molecular techniques to advance the understanding of pathophysiology, as well as to further improve the diagnosis and treatment of lung disease.
Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

This CME activity was approved for AMA PRA Category 1 Credit™ on September 16, 2014 and will terminate September, 2017.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Kaner (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Principal Investigator in IPF clinical study at Bristol-Myers Squibb; Member, RAINIER Endpoints Adjudication Committee (IPF) at Gilead Sciences; Data Monitoring Committee for Asthma and COPD clinical trials at Janssen Pharmaceuticals; Speakers Bureau for Asthma at  Merck & Co. Dr. Kaner supported his presentation and clinical recommendations with the best available evidence from the medical literature, and submitted his slides in advance for adequate peer review.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules